Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Philippines firm bids $535 million for Australia's Infigen Energy

Published 06/02/2020, 11:20 PM
Updated 06/02/2020, 11:25 PM
© Reuters. A fence is seen in front of wind turbines that are part of the Infigen Energy Capital Wind Farm located on the hills surrounding Lake George, near the Australian capital city of Canberra

By Sonali Paul and Shreya Mariam Job

MELBOURNE/BANGALORE (Reuters) - Philippine conglomerate Ayala Corp has made a bid worth A$777 million ($535 million) to buy Infigen Energy, pouncing on the Australian renewables company at a time when wind and solar firms are battling falling power prices.

UAC Energy Holdings, a joint venture of Ayala's AC Energy and Hong Kong-based UPC Renewables Group, said it would offer A$0.80 a share in cash, a 36% premium to Infigen's previous close.

Infigen's shares soared to a four-month high of A$0.81 after the bid was announced, reflecting investors' view a deal could go ahead.

"We think this takeover offer allows shareholders to crystallise value now at an attractive premium to the recent share price," Royal Bank of Canada (RBC) analyst James Nevin said in a note.

Sydney-based Infigen did not immediately respond to requests for comment.

If successful, UAC would acquire seven wind farms and a 600-megawatt pipeline of projects which Infigen recently deferred to save money amid falling wholesale power prices, COVID-19 restrictions, and challenges integrating wind and solar farms into Australia's shaky grid.

"We have ready access to capital and significant renewable energy expertise that will position us well to support Infigen’s pipeline of projects and focus on much needed renewable energy investment and associated employment in Australia," UAC Chairman Anton Rohner said in a statement.

UAC is developing four other renewables projects in Australia.

RBC's Nevin said it would make sense for shareholders to accept the offer, given Infigen has put its growth ambitions on hold, which would likely cap its share price growth in the near term.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

UAC has already acquired a 12.8% stake in Infigen.

It has set no minimum acceptance condition for the bid, so it would not need support from Infigen's top shareholder, UK activist investor TCI Fund Management, which owns 26% of Infigen, according to Refinitiv data.

TCI partners in London were not immediately available to comment outside office hours.

Credit Suisse (SIX:CSGN) is advising UAC.

($1 = 1.4514 Australian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.